Open science in precision medicine for neurodegenerative diseases
Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases. Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully develop...
Gespeichert in:
| Veröffentlicht in: | Nature reviews. Drug discovery 2024-04, Vol.23 (4), p.233-234 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 234 |
|---|---|
| container_issue | 4 |
| container_start_page | 233 |
| container_title | Nature reviews. Drug discovery |
| container_volume | 23 |
| creator | Leonard, Hampton L. Nalls, Mike A. Day-Williams, Aaron Esmaeeli, Sahar Jarreau, Paige Bandres-Ciga, Sara Heutink, Peter Sardi, S. Pablo Singleton, Andrew B. |
| description | Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.
Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases. |
| doi_str_mv | 10.1038/d41573-024-00017-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11301766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920185601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-1420abeb263957f7b511d55d4790d6130e917e0938b0197e5b8b3ab358c03a243</originalsourceid><addsrcrecordid>eNp9kctqHDEQRUVIiJ8_kEVoyCabdqr07pUxJrENBm-StVCrayYyM9JYmjb4761knMljkZUK6tRRFZexdwhnCMJ-miQqI3rgsgcANL14xQ5RGtmjsfL1vjb6gB3Vet8YjYa_ZQfCcmtQq0N2cbeh1NUQKQXqYuo2hUKsMaduTVMMMVG3yKVLNJc80ZISFb-Nj9RNsZKvVE_Ym4VfVTp9eY_Zty-fv15e97d3VzeXF7d9kFxve5Qc_Egj12JQZmFGhTgpNUkzwKRRAA1oCAZhR8DBkBrtKPwolA0gPJfimJ3vvJt5bKsFStviV25T4tqXJ5d9dH93UvzulvnRYZOj0boZPr4YSn6YqW7dOtZAq5VPlOfq-MABrdKADf3wD3qf55LafU6AEEZaLqFRfEeFkmsttNhvg-B-ROR2EbkWkfsZkRNt6P2fd-xHfmXSALEDamulJZXff_9H-wwlTptI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3033748240</pqid></control><display><type>article</type><title>Open science in precision medicine for neurodegenerative diseases</title><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Leonard, Hampton L. ; Nalls, Mike A. ; Day-Williams, Aaron ; Esmaeeli, Sahar ; Jarreau, Paige ; Bandres-Ciga, Sara ; Heutink, Peter ; Sardi, S. Pablo ; Singleton, Andrew B.</creator><creatorcontrib>Leonard, Hampton L. ; Nalls, Mike A. ; Day-Williams, Aaron ; Esmaeeli, Sahar ; Jarreau, Paige ; Bandres-Ciga, Sara ; Heutink, Peter ; Sardi, S. Pablo ; Singleton, Andrew B.</creatorcontrib><description>Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.
Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.</description><identifier>ISSN: 1474-1776</identifier><identifier>ISSN: 1474-1784</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/d41573-024-00017-3</identifier><identifier>PMID: 38287165</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Biomedicine ; Biotechnology ; Cancer Research ; Comment ; Medicinal Chemistry ; Molecular Medicine ; Pharmacology/Toxicology</subject><ispartof>Nature reviews. Drug discovery, 2024-04, Vol.23 (4), p.233-234</ispartof><rights>Springer Nature Limited 2024</rights><rights>Springer Nature Limited 2024.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-1420abeb263957f7b511d55d4790d6130e917e0938b0197e5b8b3ab358c03a243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/d41573-024-00017-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/d41573-024-00017-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38287165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leonard, Hampton L.</creatorcontrib><creatorcontrib>Nalls, Mike A.</creatorcontrib><creatorcontrib>Day-Williams, Aaron</creatorcontrib><creatorcontrib>Esmaeeli, Sahar</creatorcontrib><creatorcontrib>Jarreau, Paige</creatorcontrib><creatorcontrib>Bandres-Ciga, Sara</creatorcontrib><creatorcontrib>Heutink, Peter</creatorcontrib><creatorcontrib>Sardi, S. Pablo</creatorcontrib><creatorcontrib>Singleton, Andrew B.</creatorcontrib><title>Open science in precision medicine for neurodegenerative diseases</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><addtitle>Nat Rev Drug Discov</addtitle><description>Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.
Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.</description><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Cancer Research</subject><subject>Comment</subject><subject>Medicinal Chemistry</subject><subject>Molecular Medicine</subject><subject>Pharmacology/Toxicology</subject><issn>1474-1776</issn><issn>1474-1784</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kctqHDEQRUVIiJ8_kEVoyCabdqr07pUxJrENBm-StVCrayYyM9JYmjb4761knMljkZUK6tRRFZexdwhnCMJ-miQqI3rgsgcANL14xQ5RGtmjsfL1vjb6gB3Vet8YjYa_ZQfCcmtQq0N2cbeh1NUQKQXqYuo2hUKsMaduTVMMMVG3yKVLNJc80ZISFb-Nj9RNsZKvVE_Ym4VfVTp9eY_Zty-fv15e97d3VzeXF7d9kFxve5Qc_Egj12JQZmFGhTgpNUkzwKRRAA1oCAZhR8DBkBrtKPwolA0gPJfimJ3vvJt5bKsFStviV25T4tqXJ5d9dH93UvzulvnRYZOj0boZPr4YSn6YqW7dOtZAq5VPlOfq-MABrdKADf3wD3qf55LafU6AEEZaLqFRfEeFkmsttNhvg-B-ROR2EbkWkfsZkRNt6P2fd-xHfmXSALEDamulJZXff_9H-wwlTptI</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Leonard, Hampton L.</creator><creator>Nalls, Mike A.</creator><creator>Day-Williams, Aaron</creator><creator>Esmaeeli, Sahar</creator><creator>Jarreau, Paige</creator><creator>Bandres-Ciga, Sara</creator><creator>Heutink, Peter</creator><creator>Sardi, S. Pablo</creator><creator>Singleton, Andrew B.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240401</creationdate><title>Open science in precision medicine for neurodegenerative diseases</title><author>Leonard, Hampton L. ; Nalls, Mike A. ; Day-Williams, Aaron ; Esmaeeli, Sahar ; Jarreau, Paige ; Bandres-Ciga, Sara ; Heutink, Peter ; Sardi, S. Pablo ; Singleton, Andrew B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-1420abeb263957f7b511d55d4790d6130e917e0938b0197e5b8b3ab358c03a243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Cancer Research</topic><topic>Comment</topic><topic>Medicinal Chemistry</topic><topic>Molecular Medicine</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leonard, Hampton L.</creatorcontrib><creatorcontrib>Nalls, Mike A.</creatorcontrib><creatorcontrib>Day-Williams, Aaron</creatorcontrib><creatorcontrib>Esmaeeli, Sahar</creatorcontrib><creatorcontrib>Jarreau, Paige</creatorcontrib><creatorcontrib>Bandres-Ciga, Sara</creatorcontrib><creatorcontrib>Heutink, Peter</creatorcontrib><creatorcontrib>Sardi, S. Pablo</creatorcontrib><creatorcontrib>Singleton, Andrew B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leonard, Hampton L.</au><au>Nalls, Mike A.</au><au>Day-Williams, Aaron</au><au>Esmaeeli, Sahar</au><au>Jarreau, Paige</au><au>Bandres-Ciga, Sara</au><au>Heutink, Peter</au><au>Sardi, S. Pablo</au><au>Singleton, Andrew B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Open science in precision medicine for neurodegenerative diseases</atitle><jtitle>Nature reviews. Drug discovery</jtitle><stitle>Nat Rev Drug Discov</stitle><addtitle>Nat Rev Drug Discov</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>23</volume><issue>4</issue><spage>233</spage><epage>234</epage><pages>233-234</pages><issn>1474-1776</issn><issn>1474-1784</issn><eissn>1474-1784</eissn><abstract>Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.
Open science initiatives that harness human genomic and genetic data could help increase the likelihood of successfully developing new drugs for neurodegenerative diseases.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38287165</pmid><doi>10.1038/d41573-024-00017-3</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-1776 |
| ispartof | Nature reviews. Drug discovery, 2024-04, Vol.23 (4), p.233-234 |
| issn | 1474-1776 1474-1784 1474-1784 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11301766 |
| source | Nature Journals Online; SpringerLink Journals - AutoHoldings |
| subjects | Biomedicine Biotechnology Cancer Research Comment Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology |
| title | Open science in precision medicine for neurodegenerative diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Open%20science%20in%20precision%20medicine%20for%20neurodegenerative%20diseases&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Leonard,%20Hampton%20L.&rft.date=2024-04-01&rft.volume=23&rft.issue=4&rft.spage=233&rft.epage=234&rft.pages=233-234&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/d41573-024-00017-3&rft_dat=%3Cproquest_pubme%3E2920185601%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3033748240&rft_id=info:pmid/38287165&rfr_iscdi=true |